Quick Summary:
In an era marked by a growing focus on health and wellness, bodyweight management becomes increasingly crucial to global public health, making the anti-obesity drug market research presented in this report invaluable to forward-looking businesses. Gaining an insight into this burgeoning industry, with this report, can bolster strategic decisions and maintain a competitive edge.
The report traverses deep into the anti-obesity drug industry, providing insights on key regional markets including North America, Europe, Asia, South America, and the MEA, and highlights major players like Roche, GlaxoSmithKline, Currax Pharmaceuticals, Novo Nordisk, and Vivus Inc. In-depth competitor analysis, including company profiles, business information, SWOT analysis, sales volume, revenue, price, and gross margin, ensures you stay updated on the industry's landscape. Understanding the market share of various types of anti-obesity drugs like orlistat, naltrexone/bupropion, liraglutide, and Phentermine / Topiramate, also positions you to pinpoint emerging trends and opportunities.
For the geography segment, regional supply, demand, major players, and price is presented from 2019 to 2029.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
For the competitor segment, the report includes key players of Anti-obesity Drug as well as some small players.
The information for each competitor includes:
- Company Profile
- Main Business Information
- SWOT Analysis
- Sales Volume, Revenue, Price and Gross Margin
- Market Share
Types Segment:
- orlistat
- naltrexone/bupropion
- liraglutide
- Phentermine / Topiramate
- Others
Companies Covered:
- Roche
- GlaxoSmithKline
- Currax Pharmaceuticals
- Novo Nordisk
- Vivus Inc
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Roche
- GlaxoSmithKline
- Currax Pharmaceuticals
- Novo Nordisk
- Vivus Inc
Methodology
LOADING...